Florian Wenzl

Florian A. Wenzl, M.D., Ph.D., FESC is a physician-scientist who trained at the German Heart Center Munich, the University of Pennsylvania, and the University of Zurich. Dr. Wenzl and his team focus on cardiovascular risk prediction and precision medicine, integrating clinical cardiology, omics technologies, single-cell sequencing, cardiovascular epidemiology, and machine learning. His research has been published in leading journals across general medicine (e.g., The Lancet), cardiovascular medicine (e.g., European Heart Journal), metabolic medicine (e.g., Diabetes Care), and health informatics (e.g., The Lancet Digital Health), bridging molecular insights with unmet clinical needs through AI-driven approaches. This research programme aiming at enhanced clinical decision-making has translated into clinical risk tools, including the GRACE 3.0 and ONCO-ACS scores, which are currently in clinical use or under evaluation in randomised controlled trials funded by the European Commission (EU Horizon) and other funding bodies. For his contributions to research and education, he has received several prizes and awards, including the Ars Docendi National Prize awarded by the Austrian Minister of Education, the ESC Young Investigator Award, the Research Prize of the Swiss Society of Cardiology, the Albrecht von Haller Young Investigator Award of the Swiss Heart Foundation, and the Research Award for Medicine and Natural Sciences of the University of Zurich. He is a member of the UK Disease Registration and Analysis Service and serves on the ESC Committee on Digital Cardiology & AI, as well as on the steering committee of the Swiss National Registry of Myocardial Infarction.